Poland
  • Afghanistan
  • Åland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antarctica
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belau
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bonaire, Saint Eustatius and Saba
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • Brunei
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos (Keeling) Islands
  • Colombia
  • Comoros
  • Congo (Brazzaville)
  • Congo (Kinshasa)
  • Cook Islands
  • Costa Rica
  • Croatia
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Denmark
  • Djibouti
  • Dominica
  • Dominican Republic
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Eswatini
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and McDonald Islands
  • Honduras
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Ivory Coast
  • Jamaica
  • Japan
  • Jersey
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Libya
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macao
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • North Korea
  • North Macedonia
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palestinian Territory
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • São Tomé and Príncipe
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin (Dutch part)
  • Saint Martin (French part)
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia/Sandwich Islands
  • South Korea
  • South Sudan
  • Spain
  • Sri Lanka
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Sweden
  • Switzerland
  • Syria
  • Taiwan
  • Tajikistan
  • Tanzania
  • Thailand
  • Timor-Leste
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom (UK)
  • United States (US)
  • United States (US) Minor Outlying Islands
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican
  • Venezuela
  • Vietnam
  • Virgin Islands (British)
  • Virgin Islands (US)
  • Wallis and Futuna
  • Western Sahara
  • Yemen
  • Zambia
  • Zimbabwe
Change currency (GBP)
  • GBP
  • EUR
Nu Derma Supply logo

Nu Derma Supply

  • Change Location:
    Poland
    • Afghanistan
    • Åland Islands
    • Albania
    • Algeria
    • American Samoa
    • Andorra
    • Angola
    • Anguilla
    • Antarctica
    • Antigua and Barbuda
    • Argentina
    • Armenia
    • Aruba
    • Australia
    • Austria
    • Azerbaijan
    • Bahamas
    • Bahrain
    • Bangladesh
    • Barbados
    • Belarus
    • Belau
    • Belgium
    • Belize
    • Benin
    • Bermuda
    • Bhutan
    • Bolivia
    • Bonaire, Saint Eustatius and Saba
    • Bosnia and Herzegovina
    • Botswana
    • Bouvet Island
    • Brazil
    • British Indian Ocean Territory
    • Brunei
    • Bulgaria
    • Burkina Faso
    • Burundi
    • Cambodia
    • Cameroon
    • Canada
    • Cape Verde
    • Cayman Islands
    • Central African Republic
    • Chad
    • Chile
    • China
    • Christmas Island
    • Cocos (Keeling) Islands
    • Colombia
    • Comoros
    • Congo (Brazzaville)
    • Congo (Kinshasa)
    • Cook Islands
    • Costa Rica
    • Croatia
    • Cuba
    • Curaçao
    • Cyprus
    • Czech Republic
    • Denmark
    • Djibouti
    • Dominica
    • Dominican Republic
    • Ecuador
    • Egypt
    • El Salvador
    • Equatorial Guinea
    • Eritrea
    • Estonia
    • Eswatini
    • Ethiopia
    • Falkland Islands
    • Faroe Islands
    • Fiji
    • Finland
    • France
    • French Guiana
    • French Polynesia
    • French Southern Territories
    • Gabon
    • Gambia
    • Georgia
    • Germany
    • Ghana
    • Gibraltar
    • Greece
    • Greenland
    • Grenada
    • Guadeloupe
    • Guam
    • Guatemala
    • Guernsey
    • Guinea
    • Guinea-Bissau
    • Guyana
    • Haiti
    • Heard Island and McDonald Islands
    • Honduras
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Iran
    • Iraq
    • Ireland
    • Isle of Man
    • Israel
    • Italy
    • Ivory Coast
    • Jamaica
    • Japan
    • Jersey
    • Jordan
    • Kazakhstan
    • Kenya
    • Kiribati
    • Kuwait
    • Kyrgyzstan
    • Laos
    • Latvia
    • Lebanon
    • Lesotho
    • Liberia
    • Libya
    • Liechtenstein
    • Lithuania
    • Luxembourg
    • Macao
    • Madagascar
    • Malawi
    • Malaysia
    • Maldives
    • Mali
    • Malta
    • Marshall Islands
    • Martinique
    • Mauritania
    • Mauritius
    • Mayotte
    • Mexico
    • Micronesia
    • Moldova
    • Monaco
    • Mongolia
    • Montenegro
    • Montserrat
    • Morocco
    • Mozambique
    • Myanmar
    • Namibia
    • Nauru
    • Nepal
    • Netherlands
    • New Caledonia
    • New Zealand
    • Nicaragua
    • Niger
    • Nigeria
    • Niue
    • Norfolk Island
    • North Korea
    • North Macedonia
    • Northern Mariana Islands
    • Norway
    • Oman
    • Pakistan
    • Palestinian Territory
    • Panama
    • Papua New Guinea
    • Paraguay
    • Peru
    • Philippines
    • Pitcairn
    • Poland
    • Portugal
    • Puerto Rico
    • Qatar
    • Reunion
    • Romania
    • Russia
    • Rwanda
    • São Tomé and Príncipe
    • Saint Barthélemy
    • Saint Helena
    • Saint Kitts and Nevis
    • Saint Lucia
    • Saint Martin (Dutch part)
    • Saint Martin (French part)
    • Saint Pierre and Miquelon
    • Saint Vincent and the Grenadines
    • Samoa
    • San Marino
    • Saudi Arabia
    • Senegal
    • Serbia
    • Seychelles
    • Sierra Leone
    • Singapore
    • Slovakia
    • Slovenia
    • Solomon Islands
    • Somalia
    • South Africa
    • South Georgia/Sandwich Islands
    • South Korea
    • South Sudan
    • Spain
    • Sri Lanka
    • Sudan
    • Suriname
    • Svalbard and Jan Mayen
    • Sweden
    • Switzerland
    • Syria
    • Taiwan
    • Tajikistan
    • Tanzania
    • Thailand
    • Timor-Leste
    • Togo
    • Tokelau
    • Tonga
    • Trinidad and Tobago
    • Tunisia
    • Turkey
    • Turkmenistan
    • Turks and Caicos Islands
    • Tuvalu
    • Uganda
    • Ukraine
    • United Arab Emirates
    • United Kingdom (UK)
    • United States (US)
    • United States (US) Minor Outlying Islands
    • Uruguay
    • Uzbekistan
    • Vanuatu
    • Vatican
    • Venezuela
    • Vietnam
    • Virgin Islands (British)
    • Virgin Islands (US)
    • Wallis and Futuna
    • Western Sahara
    • Yemen
    • Zambia
    • Zimbabwe
  • Change Currency:
    GBP
    • GBP
    • EUR
  • Contact Us

MONOVISC® vs Synvisc: Properties & Treatment Course

Intraarticular injections of hyaluronic acid-based MONOVISC®, a product manufactured by Anika Therapeutics, and Synvisc, made by Genzyme, are used in the treatment of osteoarthritis of the knee.Patients considering such viscosupplements may need more information before deciding on the right product for them. Read on to learn more about the benefits of viscosupplementation and the characteristics of MONOVISC® and Synvisc.

MONOVISC® vs Synvisc for viscosupplementation

Patients with knee osteoarthritis, a type of arthritis in which the knee suffers damage due to the wearing down of its protective cartilage, often find themselves suffering from pain or joint stiffness that limits their mobility and impedes their daily activities. Managing this condition by alleviating the symptoms of knee osteoarthritis is necessary to improve patients’ quality of life.

Currently, the methods of managing knee osteoarthritis include pain medications such as acetaminophen, physical therapy, and weight loss management (if obesity is a factor). Additionally, second-line medications like intraarticular corticosteroids and intraarticular hyaluronic acid can be employed if the initial approach does not produce an adequate clinical response.

Intraarticular hyaluronic acid injections are a form of viscosupplementation therapy Viscosupplements are used to lubricate and cushion the affected joint in order to prevent further progression and reduce symptoms of the disease. They are similar in composition and physical characteristics to human synovial fluid, a component found in the knee joint that plays a vital role in its lubrication.

How do the orthopedic injections MONOVISC® and Synvisc differ?

Composition

Synvisc is unique among all hyaluronic acid viscosupplements. The main ingredient in Synvisc is a cross-linked derivative of hyaluronic acid that contains two polymers, hylan A (a soluble, high-molecular-weight molecule that makes up 80% of the compound) and hylan B (an insoluble gel-like continuous molecular network that makes up the remaining 20% of the compound) In contrast, MONOVISC® contains cross-linked hyaluronan of high molecular weight.

Hyaluronic acid sources

The hyaluronic acid in MONOVISC® is derived from bacterial fermentation, whereas the hylan in Synvisc is produced from rooster combs. Thus, patients with hypersensitivity to avian proteins, feathers and/or egg products may consider MONOVISC® to be the more suitable treatment for them.

Viscoelastic properties

It is thought that Synvisc better imitates the rheological properties of healthy synovial fluid, which could impact its effectiveness in providing adequate lubrication to the joint.

Adverse events

Synvisc is associated with acute local reactions in the knee. These reactions have been shown to increase in frequency in patients receiving more than one course of treatment. Similar reactions have not been reported with other viscosupplements, including MONOVISC®.

Treatment course

MONOVISC® is a single dose treatment course, while Synvisc requires 3 weekly injections. The former may be more convenient for patients who wish to avoid the hassle of multiple visits to the doctor.

Conclusion

Intraarticular injections of hyaluronic acid are a safe and convenient method of alleviating the symptoms associated with knee osteoarthritis. However, not all viscosupplements are the same, and patients should discuss their options with their physician.

Continue reading

ellanse results

Revealing Remarkable Ellanse Results – What to Expect

Learn about the benefits, duration, and expected outcomes of Ellanse to achieve desired aesthetic goals. The significance of dermal filler results lies not only in the immediate enhancement of facial features but also in the restoration of confidence and self-esteem for individuals. Effective outcomes from dermal filler procedures can impart…

Read More
ellanse filler side effects

Potential Ellanse Filler Side Effects: What to Expect

While Ellanse is renowned for its efficacy and longevity, it is essential to be aware of the possible adverse reactions post-treatment. By exploring the spectrum of side effects, their management strategies, and preventive measures, this article aims to equip practitioners with the knowledge and expertise needed to ensure the safety…

Read More
ellanse before and after

Ellanse Before and After – Remarkable Transformations

This article presents real-life case studies and clinical examples to give medical professionals insights into the aesthetic improvements and transformative effects that can be achieved with Ellanse. Dermal filler results are pivotal in reshaping facial contours and restoring volume lost due to aging or other factors. These outcomes often hold…

Read More
Our website is intended solely for people who use medical devices, such as dermal fillers, as professionals. It may contain product advertisements targeted only at such people. To enter Nu Derma Supply, please confirm that you are such a person (e.g. a medical professional, cosmetologist, service technician, etc.).
Decline